- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 403/06 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Patent holdings for IPC class C07D 403/06
Total number of patents in this class: 3392
10-year publication summary
|
228
|
189
|
225
|
242
|
199
|
159
|
186
|
199
|
181
|
152
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| F. Hoffmann-La Roche AG | 7937 |
63 |
| Takeda Pharmaceutical Company Limited | 2721 |
50 |
| Boehringer Ingelheim International GmbH | 4636 |
49 |
| Novartis AG | 10612 |
45 |
| Merck Sharp & Dohme LLC | 3732 |
45 |
| Janssen Pharmaceutica N.V. | 3358 |
39 |
| VALO Health, Inc. | 176 |
39 |
| Hoffmann-La Roche Inc. | 3546 |
37 |
| LG Chem, Ltd. | 17706 |
36 |
| Bristol-myers Squibb Company | 4826 |
34 |
| Achillion Pharmaceuticals, Inc. | 164 |
33 |
| Mindset Pharma Inc. | 59 |
32 |
| Bayer Pharma AG | 1048 |
27 |
| Cancer Research Technology Limited | 526 |
26 |
| Merck Patent GmbH | 5752 |
24 |
| Astex Therapeutics Limited | 231 |
24 |
| Taisho Pharmaceutical Co., Ltd. | 869 |
22 |
| Dana-Farber Cancer Institute, Inc. | 2626 |
19 |
| The Regents of the University of California | 20303 |
17 |
| Schering Corporation | 413 |
17 |
| Other owners | 2714 |